3Breer K, Girstun A, Wielqus-Kutrowska B, et al. Overexpression purification and characterization of functional calf purine nucleoside phosphoryl- ase (PNP) [J]. Prot Exo Purif,2008;61(2) :122-30.
6Matsui S,Ahlers JD,Vortmeyer AO,et al,A model for CD8 CTL tumor through an effect on 93. and regulation of tumour escape by CD4 T cells quality of CTL [J].. J Immunol, 1999 ; 163 ( 1 ) : 184-.
7Scartozzi M,Galizla E,Verdecchia L,et al.Chemotherapy for advanced gastric cancer:across the year for a standard of care[J].Expert Opin Pharmacother,2007,8(6):797.
8Louvet C,Andre T,Tigaud JM,et al.Phase 2 study of oxaliplatin.fluorouracil.and folinic acid in locally advanced or metastatic gastric cancer patients[J].J Clin Oncol,2002,20(23):4543.
9Nardi M,Azzarerello D,Maisano R,et al.FOLFOX 4 regimen as first-line chemotherapy in elderly patients with advanced gastric cancer:a safety[J].J Chemother,2007,19(1):85-89.
10Sakamoto J,Teramukai,Nakazato H,et al.Efficacy of adjuvant immunochemotherapy with OK2432 for patients with curatively resected gastric cancer:a meta-analysis of centrally randomized controlledclinicaltrials[J].Cancer Treat Bev,2003,29(1):73.
3Breer K,Girstun A,Wielqus-Kutrowska B,et al.Overexpressionpurificacation and characterization of functional calfpurine nucleoside phosphorylase(PNP)[J].Prot ExpPurif,2008,61(2):122-130.
4Zimmerer,JM,Home PH,Smith T,et al.Cytotoxic effector functionof CD4+-independent,CD8+ T cells is mediated by TNF-alpha/TNF R [J].Transplantation,2012,94( 11):1103-1110.
